Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

YM155 Exerts Potent Cytotoxic Activity Against Quiescent (G0/G1) Multiple Myeloma and Bortezomib Resistant Cells Via Inhibition of Mcl-1 and Survivin

Miyuki Ookura, MD, Tatsuya Fujii, Shinji Kishi, MD PhD, Hiroko Shigemi, MDPhD, Naoko Hosono, MDPhD, Takahiro Yamauchi, MD PhD, Takanori Ueda, MD PhD, Akira Yoshida, MD PhD

Blood (2015) 126 (23): 3023.

https://doi.org/10.1182/blood.V126.23.3023.3023

Published: 2015

Journal Articles

Go6976, a Potent FLT3 Kinase Inhibitor, Exerts Antiproliferative Activity Against Acute Myeloid Leukemia Via Inhibition Of Survivin and Mcl-1 In The Presence Of Human Serum

Akira Yoshida, MD, PhD, Kouichi Zokumasu, Takanori Ueda, MD, PhD

Blood (2013) 122 (21): 3839.

https://doi.org/10.1182/blood.V122.21.3839.3839

Published: 2013

Journal Articles

Marked Upregulations of Survivin and Aurora-B Kinase Are Associated with Disease Progression in the Myelodysplastic Syndromes,

Akira Yoshida, MD, PhD, Kouichi Zokumasu, Takahiro Yamauchi, MD, PhD, Kazutaka Takagi, MD, PhD, Shinji Kishi, MD, PhD, Yoshimasa Urasaki, MD, PhD, Kaoru Tohyama, MD, PhD, Takanori Ueda, MD, PhD

Blood (2011) 118 (21): 3823.

https://doi.org/10.1182/blood.V118.21.3823.3823

Published: 2011

Journal Articles

Prominent Elevation of Survivin Expression in High-Risk Myelodysplastic Syndrome.

Akira Yoshida, MD, PhD, Saki Tanaka, Takahiro Yamauchi, Kazutaka Takagi, Shinji Kishi, MD, PhD, Yoshimasa Urasaki, MD, PhD, Kaoru Tohyama, Takanori Ueda, MD, PhD

Blood (2009) 114 (22): 4842.

https://doi.org/10.1182/blood.V114.22.4842.4842

Published: 2009

Journal Articles

Unique Resistance Mechanism to Dexamethasone by Glutathione S-Transferase M1 Involving p38 MAPK and NF-κB Pathways, Possible Prognostic Role for Childhood ALL.

Naoko Hosono, MD, Shinji Kishi, MD., PhD., Sumiko Iho, PhD., Yoshimasa Urasaki, MD., PhD., Akira Yoshida, MD., PhD., Hisanori Kurooka, PhD., Yoshifumi Yokota, MD., PhD., Takanori Ueda, MD., PhD.

Blood (2007) 110 (11): 2375.

https://doi.org/10.1182/blood.V110.11.2375.2375

Published: 2007

NARROW

YM155 Exerts Potent Cytotoxic Activity Against Quiescent (G0/G1) Multiple Myeloma and Bortezomib Resistant Cells Via Inhibition of Mcl-1 and Survivin

Go6976, a Potent FLT3 Kinase Inhibitor, Exerts Antiproliferative Activity Against Acute Myeloid Leukemia Via Inhibition Of Survivin and Mcl-1 In The Presence Of Human Serum

Marked Upregulations of Survivin and Aurora-B Kinase Are Associated with Disease Progression in the Myelodysplastic Syndromes,

Prominent Elevation of Survivin Expression in High-Risk Myelodysplastic Syndrome.

Unique Resistance Mechanism to Dexamethasone by Glutathione S-Transferase M1 Involving p38 MAPK and NF-κB Pathways, Possible Prognostic Role for Childhood ALL.

Email alerts

ASH Publications

American Society of Hematology

YM155 Exerts Potent Cytotoxic Activity Against Quiescent (G0/G1) Multiple Myeloma and Bortezomib Resistant Cells Via Inhibition of Mcl-1 and Survivin

Go6976, a Potent FLT3 Kinase Inhibitor, Exerts Antiproliferative Activity Against Acute Myeloid Leukemia Via Inhibition Of Survivin and Mcl-1 In The Presence Of Human Serum

Marked Upregulations of Survivin and Aurora-B Kinase Are Associated with Disease Progression in the Myelodysplastic Syndromes,

Prominent Elevation of Survivin Expression in High-Risk Myelodysplastic Syndrome.

Unique Resistance Mechanism to Dexamethasone by Glutathione S-Transferase M1 Involving p38 MAPK and NF-κB Pathways, Possible Prognostic Role for Childhood ALL.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only